FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273124893> ?p ?o ?g. }

• W2273124893 endingPage "476" @default.
• W2273124893 startingPage "459" @default.
• W2273124893 abstract "The maximally tolerated dose (MTD) of cytotoxic agents has historical precedence in treating cancer, as it was believed that dose and therapeutic effect are intrinsically linked and that the MTD would provide greatest therapeutic value. With molecularly targeted agents, the premise of preventing toxicity to normal tissues while modulating tumor growth provides a potential for an increased therapeutic window. Results from these targeted agents suggest we are entering an era of chronic cancer management, which will require design of regimens with long-term tolerability. A corresponding switch from MTD-based (toxicity-driven) dosing strategies to alternative paradigms is also expected. The challenge with these targeted agents is to fully understand the complex relationship between pharmacokinetics, pharmacodynamics, and safety and efficacy in early-stage trials, so that the optimal dose and schedule for registration trials may be identified. This review provides a systematic survey of the applications submitted to the United States Food and Drug Administration (FDA) for oncology indications, from 2010 through early 2015, and summarizes the dose selection rationale for registrational trials, the relationship of the MTD to outcomes of the final label dose, the postmarketing requirements or commitments related to dose optimization activities, the role of biomarkers, and typical exposure–response modeling methods." @default.
• W2273124893 created "2016-06-24" @default.
• W2273124893 creator A5007469278 @default.
• W2273124893 creator A5011946503 @default.
• W2273124893 creator A5016706552 @default.
• W2273124893 creator A5022619396 @default.
• W2273124893 creator A5033351939 @default.
• W2273124893 creator A5062831066 @default.
• W2273124893 creator A5064009743 @default.
• W2273124893 creator A5082723850 @default.
• W2273124893 creator A5089004534 @default.
• W2273124893 date "2016-01-25" @default.
• W2273124893 modified "2023-10-16" @default.
• W2273124893 title "A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities" @default.
• W2273124893 cites W1501566740 @default.
• W2273124893 cites W1977180561 @default.
• W2273124893 cites W1986188871 @default.
• W2273124893 cites W2024447346 @default.
• W2273124893 cites W2064651476 @default.
• W2273124893 cites W2086061321 @default.
• W2273124893 cites W2089137624 @default.
• W2273124893 cites W2091666474 @default.
• W2273124893 cites W2098461478 @default.
• W2273124893 cites W2100738068 @default.
• W2273124893 cites W2112196468 @default.
• W2273124893 cites W2113038732 @default.
• W2273124893 cites W2114991862 @default.
• W2273124893 cites W2115125611 @default.
• W2273124893 cites W2123709211 @default.
• W2273124893 cites W2416957871 @default.
• W2273124893 cites W2600384146 @default.
• W2273124893 cites W850470413 @default.
• W2273124893 doi "https://doi.org/10.1007/s00280-015-2931-4" @default.
• W2273124893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4767861" @default.
• W2273124893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26811176" @default.
• W2273124893 hasPublicationYear "2016" @default.
• W2273124893 type Work @default.
• W2273124893 sameAs 2273124893 @default.
• W2273124893 citedByCount "43" @default.
• W2273124893 countsByYear W22731248932016 @default.
• W2273124893 countsByYear W22731248932017 @default.
• W2273124893 countsByYear W22731248932018 @default.
• W2273124893 countsByYear W22731248932019 @default.
• W2273124893 countsByYear W22731248932020 @default.
• W2273124893 countsByYear W22731248932021 @default.
• W2273124893 countsByYear W22731248932022 @default.
• W2273124893 countsByYear W22731248932023 @default.
• W2273124893 crossrefType "journal-article" @default.
• W2273124893 hasAuthorship W2273124893A5007469278 @default.
• W2273124893 hasAuthorship W2273124893A5011946503 @default.
• W2273124893 hasAuthorship W2273124893A5016706552 @default.
• W2273124893 hasAuthorship W2273124893A5022619396 @default.
• W2273124893 hasAuthorship W2273124893A5033351939 @default.
• W2273124893 hasAuthorship W2273124893A5062831066 @default.
• W2273124893 hasAuthorship W2273124893A5064009743 @default.
• W2273124893 hasAuthorship W2273124893A5082723850 @default.
• W2273124893 hasAuthorship W2273124893A5089004534 @default.
• W2273124893 hasBestOaLocation W22731248931 @default.
• W2273124893 hasConcept C111113717 @default.
• W2273124893 hasConcept C112705442 @default.
• W2273124893 hasConcept C126322002 @default.
• W2273124893 hasConcept C143998085 @default.
• W2273124893 hasConcept C177713679 @default.
• W2273124893 hasConcept C197934379 @default.
• W2273124893 hasConcept C19831878 @default.
• W2273124893 hasConcept C2777288759 @default.
• W2273124893 hasConcept C2777334693 @default.
• W2273124893 hasConcept C2778375690 @default.
• W2273124893 hasConcept C2780035454 @default.
• W2273124893 hasConcept C535046627 @default.
• W2273124893 hasConcept C64903051 @default.
• W2273124893 hasConcept C71924100 @default.
• W2273124893 hasConcept C98274493 @default.
• W2273124893 hasConceptScore W2273124893C111113717 @default.
• W2273124893 hasConceptScore W2273124893C112705442 @default.
• W2273124893 hasConceptScore W2273124893C126322002 @default.
• W2273124893 hasConceptScore W2273124893C143998085 @default.
• W2273124893 hasConceptScore W2273124893C177713679 @default.
• W2273124893 hasConceptScore W2273124893C197934379 @default.
• W2273124893 hasConceptScore W2273124893C19831878 @default.
• W2273124893 hasConceptScore W2273124893C2777288759 @default.
• W2273124893 hasConceptScore W2273124893C2777334693 @default.
• W2273124893 hasConceptScore W2273124893C2778375690 @default.
• W2273124893 hasConceptScore W2273124893C2780035454 @default.
• W2273124893 hasConceptScore W2273124893C535046627 @default.
• W2273124893 hasConceptScore W2273124893C64903051 @default.
• W2273124893 hasConceptScore W2273124893C71924100 @default.
• W2273124893 hasConceptScore W2273124893C98274493 @default.
• W2273124893 hasIssue "3" @default.
• W2273124893 hasLocation W22731248931 @default.
• W2273124893 hasLocation W22731248932 @default.
• W2273124893 hasLocation W22731248933 @default.
• W2273124893 hasLocation W22731248934 @default.
• W2273124893 hasOpenAccess W2273124893 @default.
• W2273124893 hasPrimaryLocation W22731248931 @default.
• W2273124893 hasRelatedWork W147887991 @default.
• W2273124893 hasRelatedWork W152845527 @default.
• W2273124893 hasRelatedWork W2059221883 @default.

• next